We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.02%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DNB
2876
DELISTED
Dun & Bradstreet
DNB
$62.4K ﹤0.01%
5,394
+187
+4% +$2.03K
HRTX icon
2877
Heron Therapeutics
HRTX
$64.7M
$62.1K ﹤0.01%
53,564
RBOT
2878
DELISTED
Vicarious Surgical
RBOT
$60.9K ﹤0.01%
1,109
MRVI icon
2879
Maravai LifeSciences
MRVI
$861M
$59.9K ﹤0.01%
4,822
-1,831
-28% -$24.7K
TPG icon
2880
TPG
TPG
$8.16B
$59.8K ﹤0.01%
+2,044
New +$57.4K
WHWK
2881
Whitehawk Therapeutics
WHWK
$269M
$59.5K ﹤0.01%
+8,693
New +$67.6K
WLFC icon
2882
Willis Lease Finance
WLFC
$1.21B
$59K ﹤0.01%
+4,527
New +$70K
VSAT icon
2883
Viasat
VSAT
$12B
$58.8K ﹤0.01%
1,424
-80
-5% -$3.11K
XAIR icon
2884
Beyond Air
XAIR
$5.37M
$58.3K ﹤0.01%
+34
New +$77.7K
SSRM icon
2885
SSR Mining
SSRM
$6.63B
$57.9K ﹤0.01%
4,084
-182
-4% -$2.75K
SIRI icon
2886
SiriusXM
SIRI
$9.59B
$57.8K ﹤0.01%
1,276
-178
-12% -$6.72K
TVRD
2887
Tvardi Therapeutics
TVRD
$22.1M
$57K ﹤0.01%
560
NGM
2888
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$55.6K ﹤0.01%
21,464
+13,459
+168% +$48K
ZG icon
2889
Zillow
ZG
$7.53B
$53.8K ﹤0.01%
1,094
-209
-16% -$9.42K
AGR
2890
DELISTED
Avangrid, Inc.
AGR
$53K ﹤0.01%
1,406
-61
-4% -$2.39K
CNM icon
2891
Core & Main
CNM
$8.62B
$52.6K ﹤0.01%
1,678
-840
-33% -$22.5K
HHH icon
2892
Howard Hughes
HHH
$3.98B
$52.6K ﹤0.01%
699
-96
-12% -$6.95K
VSXY
2893
Victoria's Secret
VSXY
$7.39B
$52.3K ﹤0.01%
2,999
-48,882
-94% -$1.23M
CRBG icon
2894
Corebridge Financial
CRBG
$15.1B
$51.7K ﹤0.01%
2,929
+1,269
+76% +$21.2K
PYCR
2895
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$50.8K ﹤0.01%
2,147
+889
+71% +$20.7K
NCNO icon
2896
nCino
NCNO
$2.08B
$49.4K ﹤0.01%
1,639
-352
-18% -$8.96K
LSXMA
2897
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$48.2K ﹤0.01%
2,001
-1,246
-38% -$26.5K
QS icon
2898
QuantumScape Corp
QS
$3.92B
$46.5K ﹤0.01%
5,826
+487
+9% +$3.39K
CWEN icon
2899
Clearway Energy Class C
CWEN
$7.06B
$46.3K ﹤0.01%
1,622
-42,034
-96% -$1.27M
HPK icon
2900
HighPeak Energy
HPK
$912M
$45.6K ﹤0.01%
4,193

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.